Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novexel SA

Division of AstraZeneca PLC
www.novexel.com

Latest From Novexel SA

Appointments: Hikma, Ipsen, PeptiDream, Targovax, Moderna and Perrigo

The latest biopharma industry appointments include C-suite hires at Hikma, Ipsen, Sinclair PeptiDream, Targovax, Nicox, Moderna, Antabio and Perrigo; as well as a supervisory board appointment at Kiadis.

Appointments BioPharmaceutical

AZ Spins Out Entasis To Tackle Resistant Infections

AstraZeneca has, after a long gestation, given birth to the antibiotic developer Entasis Therapeutics: in early July the biotech debuted with $40 million in funding from AZ alone, and a portfolio of the drugmaker’s early-stage antibiotic candidates. It emerges as the debate about incentivizing antibiotics R&D intensifies amid growing concerns about antibiotic-resistant bacteria.

BioPharmaceutical Strategy

Spinifex makes two appointments

Spinifex Pharmaceuticals, a company developing new drugs for the treatment of chronic pain, has made two new appointments to enhance its chemistry, manufacturing and controls (CMC) capabilities. Dr Peter Spargo has joined Spinifex as senior vice-president, CMC. Previously Dr Spargo acted as an industry consultant, including to Spinifex, and held the role of SVP CMC at Creabilis (Italy and UK) and at Novexel (France).

Neurology France

Drug Development Wish List: Antibiotic Data Cravings Seen At Actavis Cmte. Review

Despite voting for two of three proposed indications for gram-negative antibiotic ceftazidime/avibactam, many FDA committee members pressed for additional studies and analyses, offering hints for future antibiotic advisory panels as well as potential post-market requirements for Actavis.

BioPharmaceutical North America
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • AstraZeneca PLC
  • Senior Management
  • Iain Buchanan, CEO
    Kenneth Coleman, PhD, CSO
    Carole Sable, MD, CMO
    Aram Mangasarian, VP, Bus. Dev.
  • Contact Info
  • Novexel SA
    Phone: (33) 57 14 07 77
    102, avenue Gaston Roussel
    Romaineville, 93230
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register